{"DataElement":{"publicId":"5608361","version":"1.1","preferredName":"Treatment Cohort Study 9681 Code","preferredDefinition":"The code that represents the information pertaining to protocol 9681 in which subsets of a defined population are identified.","longName":"TX_COHRT_SDY_9681_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5608353","version":"1.1","preferredName":"9681 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"5608353v1.1","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SG05","valueDescription":"SG05: Adenocarcinoma/urachal of the bladder","ValueMeaning":{"publicId":"5608358","version":"1","preferredName":"SG05: Adenocarcinoma/urachal of the bladder","longName":"5608358","preferredDefinition":"SG05: Adenocarcinoma/urachal of the bladder","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441AFA7F-01F3-531D-E053-F662850AD6F6","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2016-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"724F54D1-9A47-7B1F-E053-F662850AC48C","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"ONEDATA","dateModified":"2018-07-31","deletedIndicator":"No"},{"value":"SG04","valueDescription":"SG04: Bladder cancer-refractory to prior immunotherapy checkpoint inhibition","ValueMeaning":{"publicId":"5608359","version":"1","preferredName":"SG04: Bladder cancer-refractory to prior immunotherapy checkpoint inhibition","longName":"5608359","preferredDefinition":"SG04: Bladder cancer-refractory to prior immunotherapy checkpoint inhibition","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441AFA7F-0216-531D-E053-F662850AD6F6","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2016-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"724F54D1-9A51-7B1F-E053-F662850AC48C","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"ONEDATA","dateModified":"2018-07-31","deletedIndicator":"No"},{"value":"SG03","valueDescription":"SG03: Rectal cancer","ValueMeaning":{"publicId":"5608360","version":"1","preferredName":"SG03: Rectal cancer","longName":"5608360","preferredDefinition":"SG03: Rectal cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441AFA7F-0239-531D-E053-F662850AD6F6","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2016-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"724F54D1-9A5B-7B1F-E053-F662850AC48C","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"ONEDATA","dateModified":"2018-07-31","deletedIndicator":"No"},{"value":"SG02","valueDescription":"SG02: Bladder cancer","ValueMeaning":{"publicId":"5608354","version":"1","preferredName":"SG02: Bladder cancer","longName":"5608354","preferredDefinition":"SG02: Bladder cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441AD12C-AB71-1006-E053-F662850A55CE","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"724F54D1-9A65-7B1F-E053-F662850AC48C","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"ONEDATA","dateModified":"2018-07-31","deletedIndicator":"No"},{"value":"SG01","valueDescription":"SG01: All patients for Part 1 and Part 2","ValueMeaning":{"publicId":"5608355","version":"1","preferredName":"SG01: All patients for Part 1 and Part 2","longName":"5608355","preferredDefinition":"SG01: All patients for Part 1 and Part 2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"441AD12C-AB94-1006-E053-F662850A55CE","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"724F54D1-9A6F-7B1F-E053-F662850AC48C","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"ONEDATA","dateModified":"2018-07-31","deletedIndicator":"No"},{"value":"SG07","valueDescription":"SG07: Penile Cancer Expansion cohort","ValueMeaning":{"publicId":"5854596","version":"1","preferredName":"SG07: Penile Cancer Expansion cohort","longName":"5854596","preferredDefinition":"SG07: Penile Cancer Expansion cohort","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"514FDF56-A102-1939-E053-F662850A3383","latestVersionIndicator":"Yes","beginDate":"2017-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"724F54D1-9A79-7B1F-E053-F662850AC48C","beginDate":"2017-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"ONEDATA","dateModified":"2018-07-31","deletedIndicator":"No"},{"value":"SG06","valueDescription":"SG06: Rare Histologies","ValueMeaning":{"publicId":"6380388","version":"1","preferredName":"SG06: Rare Histologies","longName":"6380388","preferredDefinition":"SG06: Rare Histologies","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"724F54D1-9A94-7B1F-E053-F662850AC48C","latestVersionIndicator":"Yes","beginDate":"2018-07-31","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"ONEDATA","dateModified":"2018-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"724F54D1-9AAD-7B1F-E053-F662850AC48C","beginDate":"2018-07-31","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"ONEDATA","dateModified":"2018-07-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"724F54D1-9A27-7B1F-E053-F662850AC48C","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"SOKKERL","dateModified":"2018-11-08","changeDescription":"7/31/18 Version 1.1 -deleted PVs  SG06 and replaced with a new PV meaning  per Theradex  12/20/16 tt, ls - 9681.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Patient Subgroup","type":"Preferred Question Text","description":"Patient Subgroup","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7250ACDA-E320-0BB6-E053-F662850A1F46","latestVersionIndicator":"Yes","beginDate":"2016-12-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-07-31","modifiedBy":"SOKKERL","dateModified":"2018-11-08","changeDescription":"7/31/18 Version VD to Change PVs: 12/20/2016 TT/LS-9681","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}